PlainRecalls
FDA Drug Moderate Class II Terminated

Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05

Reported: November 29, 2017 Initiated: September 28, 2017 #D-0085-2018

Product Description

Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05

Reason for Recall

Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam

Details

Recalling Firm
Leading Pharma, LLC
Units Affected
2952 500-count bottles
Distribution
Nationwide in the USA
Location
Fairfield, NJ

Frequently Asked Questions

What product was recalled?
Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05. Recalled by Leading Pharma, LLC. Units affected: 2952 500-count bottles.
Why was this product recalled?
Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
Which agency issued this recall?
This recall was issued by the FDA Drug on November 29, 2017. Severity: Moderate. Recall number: D-0085-2018.